(Total Views: 143)
Posted On: 10/10/2023 8:24:34 AM
Post# of 99103
$HALB Hartman, CEO, and Dr. Felder, CTO of Halberd Corp, Featured on The Street Reports Podcast
https://www.accesswire.com/791396/hartman-ceo...ts-podcast
JACKSON CENTER, PA / ACCESSWIRE / October 10, 2023 / Halberd Corporation (OTC PINK:HALB) Chairman, President and CEO William A. Hartman and Chief Technology Officer, Dr Mitchell S. Felder were recently interviewed on "The Street Reports Podcast" to update the public on several of the company's important projects:
The significant results to-date of Halberd's proprietary nasal spray testing at Mississippi State University to mitigate the adverse effects of Traumatic Brain Injury (TBI)
Progress in securing a partnership with Athena GTX
Continuing studies at Youngstown State University
Sponsored Research project at Stanford University Medical School examining TBI treatments and Multiple Sclerosis.
Listen here: https://thestreetreports.com/halbs-ceo-willia...isten-now/
https://www.accesswire.com/791396/hartman-ceo...ts-podcast
JACKSON CENTER, PA / ACCESSWIRE / October 10, 2023 / Halberd Corporation (OTC PINK:HALB) Chairman, President and CEO William A. Hartman and Chief Technology Officer, Dr Mitchell S. Felder were recently interviewed on "The Street Reports Podcast" to update the public on several of the company's important projects:
The significant results to-date of Halberd's proprietary nasal spray testing at Mississippi State University to mitigate the adverse effects of Traumatic Brain Injury (TBI)
Progress in securing a partnership with Athena GTX
Continuing studies at Youngstown State University
Sponsored Research project at Stanford University Medical School examining TBI treatments and Multiple Sclerosis.
Listen here: https://thestreetreports.com/halbs-ceo-willia...isten-now/
(0)
(0)
